A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study

被引：0
作者：
Taiga Otsuka
Tsuyoshi Shirakawa
Mototsugu Shimokawa
Futa Koga
Yasunori Kawaguchi
Yujiro Ueda
Junichi Nakazawa
Azusa Komori
Satoshi Otsu
Shiho Arima
Masaru Fukahori
Yoshinobu Okabe
Akitaka Makiyama
Hiroki Taguchi
Takuya Honda
Taro Shibuki
Kenta Nio
Yasushi Ide
Toshihiko Mizuta
Kenji Mitsugi
Norio Ureshino
机构：
[1] Saga Medical Center Koseikan,Department of Medical Oncology
[2] Minato Medical Clinic,Department of Internal Medicine
[3] Fukuoka Wajiro Hospital,Department of Medical Oncology
[4] Karatsu Higashi-Matsuura Medical Association Center,Clinical Research Institute
[5] National Kyushu Cancer Center,Department of Biostatistics
[6] Yamaguchi University Graduate School of Medicine,Department of Hepatobiliary and Pancreatology
[7] Saga Medical Center Koseikan,Department of Gastroenterology
[8] Asakura Medical Association Hospital,Department of Hematology and Oncology
[9] Japanese Red Cross Kumamoto Hospital,Department of Medical Oncology
[10] Kagoshima City Hospital,Department of Medical Oncology and Hematology
[11] Oita University Faculty of Medicine,Digestive and Lifestyle Diseases
[12] Kagoshima University Graduate School of Medical and Dental Sciences,Department of Internal Medicine, Division of Gastroenterology
[13] Kurume University Hospital,Department of Hematology/Oncology
[14] Japan Community Healthcare Organization Kyushu Hospital,Department of Gastroenterology
[15] Cancer Center,Department of Gastroenterology
[16] Gifu University Hospital,Department of Gastroenterology and Hepatology
[17] Saiseikai Sendai Hospital,Department of Internal Medicine
[18] Izumi General Medical Center,Department of Hepatobiliary and Pancreatic Oncology
[19] Nagasaki University Graduate School of Biomedical Sciences,Department of Medical Oncology
[20] Imari Arita Kyoritsu Hospital,Department of Internal Medicine
[21] Saga,Department of Internal Medicine
[22] National Cancer Center Hospital East,Department of Medical Oncology
[23] Sasebo Kyosai Hospital,Department of Medical Oncology
[24] Karatsu Red Cross Hospital,undefined
[25] Fujikawa Hospital,undefined
[26] Hamanomachi Hospital,undefined
[27] Kimitsu Chuo Hospital,undefined
来源：
International Journal of Clinical Oncology | 2021年 / 26卷
关键词：
Pancreatic cancer; FOLFIRINOX; Gemcitabine; Nab-paclitaxel; Propensity score analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：941 / 950
页数：9
相关论文
共 50 条
[21]   An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) plus gemcitabine vs gemcitabine alone for metastatic pancreatic cancer patients: the APICE study [J].
Lazzaro, Carlo ;
Barone, Carlo ;
Caprioni, Francesco ;
Cascinu, Stefano ;
Falcone, Alfredo ;
Maiello, Evaristo ;
Milella, Michele ;
Pinto, Carmine ;
Reni, Michele ;
Tortora, Giampaolo .
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2018, 18 (04) :435-446
[22]   Nab-paclitaxel plus S-1 versus nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer: a multicenter, randomized, phase II study [J].
Jin, Min ;
Liu, Hong-Li ;
Xue, Jun ;
Ma, Hong ;
Liu, Jun-Li ;
Lin, Zhen-Yu ;
Wang, Jing ;
Bao, Le-Qun ;
Luo, Zhi-Guo ;
Yu, Xiong-Jie ;
Li, Shuang ;
Hu, Jian-Li ;
Zhang, Tao .
ONCOLOGIST, 2024, 29 (10) :e1406-e1418
[23]   Economic evaluation for the US of nab-paclitaxel plus gemcitabine versus FOLFIRINOX versus gemcitabine in the treatment of metastatic pancreas cancer [J].
Gharaibeh, Mahdi ;
McBride, Ali ;
Bootman, J. Lyle ;
Patel, Hitendra ;
Abraham, Ivo .
JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (04) :345-352
[24]   Cost-effectiveness analysis of nab-paclitaxel plus gemcitabine versus folfirinox in the treatment of metastatic pancreatic cancer in china [J].
Cui, Jiujie ;
Zhang, Xiaochen ;
Qu, Shuli ;
Wang, Liwei .
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2021, 21 (04) :691-697
[25]   Real-world outcomes of FOLFIRINOX vs gemcitabine and nab-paclitaxel in advanced pancreatic cancer: A population-based propensity score-weighted analysis [J].
Chan, Kelvin K. W. ;
Guo, Helen ;
Cheng, Sierra ;
Beca, Jaclyn M. ;
Redmond-Misner, Ruby ;
Isaranuwatchai, Wanrudee ;
Qiao, Lucy ;
Earle, Craig ;
Berry, Scott R. ;
Biagi, James J. ;
Welch, Stephen ;
Meyers, Brandon M. ;
Mittmann, Nicole ;
Coburn, Natalie ;
Arias, Jessica ;
Schwartz, Deborah ;
Dai, Wei F. ;
Gavura, Scott ;
McLeod, Robin ;
Kennedy, Erin D. .
CANCER MEDICINE, 2020, 9 (01) :160-169
[26]   Modified FOLFIRINOX as a second-line therapy following gemcitabine plus nab-paclitaxel therapy in metastatic pancreatic cancer [J].
Sawada, Masashi ;
Kasuga, Akiyoshi ;
Mie, Takafumi ;
Furukawa, Takaaki ;
Taniguchi, Takanobu ;
Fukuda, Koshiro ;
Yamada, Yuto ;
Takeda, Tsuyoshi ;
Kanata, Ryo ;
Matsuyama, Masato ;
Sasaki, Takashi ;
Ozaka, Masato ;
Sasahira, Naoki .
BMC CANCER, 2020, 20 (01)
[27]   Modified FOLFIRINOX as a second-line therapy following gemcitabine plus nab-paclitaxel therapy in metastatic pancreatic cancer [J].
Masashi Sawada ;
Akiyoshi Kasuga ;
Takafumi Mie ;
Takaaki Furukawa ;
Takanobu Taniguchi ;
Koshiro Fukuda ;
Yuto Yamada ;
Tsuyoshi Takeda ;
Ryo Kanata ;
Masato Matsuyama ;
Takashi Sasaki ;
Masato Ozaka ;
Naoki Sasahira .
BMC Cancer, 20
[28]   Efficacy and safety of second-line nab-paclitaxel plus gemcitabine after progression on FOLFIRINOX for unresectable or metastatic pancreatic ductal adenocarcinoma: multicenter retrospective analysis [J].
Chae, Heejung ;
Jeong, Hyehyun ;
Cheon, Jaekyung ;
Chon, Hong Jae ;
Ryu, Hyewon ;
Kim, Il-Hwan ;
Kang, Myoung Joo ;
Jeong, Jae Ho ;
Ryoo, Baek-Yeol ;
Kim, Kyu-pyo ;
Yoo, Changhoon .
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
[29]   A Retrospective Study of Gemcitabine Plus Nab-Paclitaxel for Advanced Pancreatic Cancer Refractory to Gemcitabine Monotherapy [J].
Nishioka, Mariko ;
Okano, Naohiro ;
Wakabayashi, Masashi ;
Ikeno, Takashi ;
Hayashi, Masato ;
Mizutani, Tomonori ;
Nagashima, Fumio ;
Furuse, Junji .
ANTICANCER RESEARCH, 2024, 44 (03) :1233-1239
[30]   Clinical Outcomes and Safety of Patients Treated with NAb-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Cancer: The NAPA Study [J].
Catalano, Martina ;
Roviello, Giandomenico ;
Conca, Raffaele ;
D'Angelo, Alberto ;
Palmieri, Valeria Emma ;
Panella, Benedetta ;
Petrioli, Roberto ;
Ianza, Anna ;
Nobili, Stefania ;
Mini, Enrico ;
Ramello, Monica .
CURRENT CANCER DRUG TARGETS, 2020, 20 (11) :887-895
12345